Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Disclosure statements are available on the authors' profiles:
Updated Overall Survival and PD-L1 Subgroup Analysis of Patients With Extensive-Stage Small-Cell Lung Cancer Treated With Atezolizumab, Carboplatin, and Etoposide (IMpower133)J. Clin. Oncol 2021 Jan 13;[EPub Ahead of Print], SV Liu, M Reck, AS Mansfield, T Mok, A Scherpereel, N Reinmuth, MC Garassino, J De Castro Carpeno, R Califano, M Nishio, F Orlandi, J Alatorre-Alexander, T Leal, Y Cheng, JS Lee, S Lam, M McCleland, Y Deng, S Phan, L Horn
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.